Alpha Cognition Inc. Common Stock
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ACOG | CGTX | ACIU | ALEC | ABOS | PMN | |
|---|---|---|---|---|---|---|
| Market cap | 185.77M | 64.98M | 227.69M | 254.58M | 15.64M | 31.57M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -13.8 | -3.1 | 3.8 | -3.1 | -0.4 | -0.8 |
| Price/book | 3.5 | 2.0 | 4.3 | -25.6 | 0.5 | 0.6 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +39.46% | −58.58% | −39.07% | +63.35% | −88.47% | −66.73% |
| Today | +4.02% | −2.32% | +9.57% | +11.22% | −7.72% | +3.23% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ACOG news ›Alpha Cognition to Report Third Quarter 2026 Financial Results and Provide Business Update
VANCOUVER, British Columbia & DALLAS--(BUSINESS WIRE)--Alpha Cognition Inc. (Nasdaq: ACOG), a biopharmaceutical company dedicated to advancing treatments for neurodegenerative diseases, today announced that it will report its third quarter…
Alpha Cognition Announces Publication of U.S. Patent Application Relating to Proprietary Manufacturing Process for ZUNVEYL®
Alpha Cognition Announces Publication of U.S. Patent Application Relating to Proprietary Manufacturing Process for ZUNVEYL BioSpace Alpha Cognition Announces Publication of U.S. Patent Application Relating to Proprietary Manufacturing…
Alpha Cognition Inc. (NASDAQ:ACOG) Receives Average Recommendation of “Buy” from Brokerages
Shares of Alpha Cognition Inc. (NASDAQ:ACOG – Get Free Report) have earned a consensus rating of “Buy” from the five brokerages that are covering the stock, Marketbeat reports. Five investment analysts have rated the stock with a buy…
Alpha Cognition to Present New ZUNVEYL® (Benzgalantamine) Clinical and Real-World Data at ASCP Annual Meeting and NEI Fall Congress
The Company will present the following posters: About Alpha Cognition Inc. Alpha Cognition Inc. is a commercial stage, biopharmaceutical company dedicated to developing treatments for patients with neurodegenerative diseases, such as…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- biospace.com2
- businesswire.com1
- defenseworld.net1
- stocktitan.net1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 5 articles, not a forecast.